[PDF][PDF] Plasma factor VIII levels as a biomarker for venous thromboembolism
LF Bittar, EV De Paula, A Barnabé… - Biomarkers in …, 2015 - researchgate.net
Plasma Factor VIII Levels as a Biomarker for Venous Thromboembolism Page 1 Plasma Factor
VIII Levels as a Biomarker for Venous Thromboembolism Luis F. Bittar, Erich V. De Paula …
VIII Levels as a Biomarker for Venous Thromboembolism Luis F. Bittar, Erich V. De Paula …
Genetic variations in sites of affinity between FVIII and LRP1 are not associated with high FVIII levels in venous thromboembolism
LF Bittar, LH Siqueira, FA Orsi, EV De Paula… - Scientific reports, 2015 - nature.com
Increased factor VIII (FVIII) levels are a prevalent and independent risk factor for venous
thromboembolism (VTE). The low density lipoprotein receptor-related protein 1 (LRP1) has …
thromboembolism (VTE). The low density lipoprotein receptor-related protein 1 (LRP1) has …
Relationship Between Elevated FVIII Level and 3'UTR Variations of F8 Gene in Turkish Patients with Venous Thrombosis
M Ay - Artuklu International Journal of Health Sciences, 2022 - dergipark.org.tr
Objective: Venous Thrombosis (VT) is an important medical disorder caused by genetic and
environmental factors. This study investigated the sequence variants in the 3'untranslated …
environmental factors. This study investigated the sequence variants in the 3'untranslated …
Acquired activated protein C resistance in sarcoma patients
Acquired activated protein C resistance (aAPCR) is seen more frequently in solid and
hematological cancer patients. We aimed to investigate the presence of aAPCR and the …
hematological cancer patients. We aimed to investigate the presence of aAPCR and the …
[HTML][HTML] The relation between soluble endothelial protein C receptor and factor VIII levels and FVIII/sEPCR index in healthy infants
OBJECTIVE: Both soluble endothelial protein C receptor (sEPCR) and factor VIII (FVIII)
seem to be potential mediators in thrombotic and inflammatory states. The aim of the present …
seem to be potential mediators in thrombotic and inflammatory states. The aim of the present …
[PDF][PDF] " AVALIAÇÃO DA EXPRESSÃO PROTEICA E DE ALTERAÇÕES MOLECULARES DO RECEPTOR HEPÁTICO LRP1 E SUA CORRELAÇÃO COM OS NÍVEIS …
LFB Sckayer - repositorio.unicamp.br
5.1 Metodologia I-Pacientes com TEV e Controles 67 5.1. 1 Dosagem plasmática da
atividade do Fator VIII 67 5.1. 2 Dosagem sérica de Proteína C Reativa (PCR) 68 5.1. 3 …
atividade do Fator VIII 67 5.1. 2 Dosagem sérica de Proteína C Reativa (PCR) 68 5.1. 3 …
[引用][C] Risk Factors of Coronary Thrombosis in Sudanese Patients Less than 50 Years Old
MELHELT Makky - University of Khartoum